This is Snapshot #3 for FHIR R5, released to support Connectathon 32. For a full list of available versions, see the Directory of published versions.
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Example of conditiondefinition
{ "resourceType" : "ConditionDefinition", "id" : "example", "text" : { "status" : "generated", "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ConditionDefinition</b><a name=\"example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ConditionDefinition "example" </p></div><p><b>url</b>: <code>http://hl7.org/fhir/ConditionDefinition/example</code></p><p><b>identifier</b>: id: urn:oid:2.16.840.1.113883.4.642.25.1</p><p><b>name</b>: Hyperlipidemia</p><p><b>title</b>: Hyperlipidemia Status</p><p><b>status</b>: draft</p><p><b>date</b>: 2019-05-26T10:44:00+10:00</p><p><b>code</b>: Hyperlipidemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#55822004)</span></p><p><b>hasSeverity</b>: false</p><p><b>hasBodySite</b>: false</p><p><b>hasStage</b>: false</p><p><b>definition</b>: <a href=\"https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf\">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a></p><blockquote><p><b>observation</b></p><p><b>code</b>: Lipid Panel <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#24331-1 "Lipid 1996 panel - Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35200-5 "Cholesterol [Moles/volume] in Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Triglyceride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35217-9 "Triglyceride [Moles/volume] in Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol in HDL <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#2085-9 "HDL Cholesterol")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: LDL Chol. (Calc) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#13457-7 "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation")</span></p></blockquote><h3>Medications</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Gemfibrozil <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/4.0.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#203151)</span></td></tr></table><h3>Plans</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a href=\"broken-link.html\">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a></td></tr></table></div>" }, "url" : "http://hl7.org/fhir/ConditionDefinition/example", "identifier" : [{ "system" : "urn:ietf:rfc:3986", "value" : "urn:oid:2.16.840.1.113883.4.642.25.1" }], "name" : "Hyperlipidemia", "title" : "Hyperlipidemia Status", "status" : "draft", "date" : "2019-05-26T10:44:00+10:00", "code" : { "coding" : [{ "system" : "http://snomed.info/sct", "code" : "55822004", "display" : "Hyperlipidemia (disorder)" }] }, "hasSeverity" : false, "hasBodySite" : false, "hasStage" : false, "definition" : ["https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"], "observation" : [{ "code" : { "coding" : [{ "system" : "http://loinc.org", "code" : "24331-1", "display" : "Lipid 1996 panel - Serum or Plasma" }], "text" : "Lipid Panel" } }, { "code" : { "coding" : [{ "system" : "http://loinc.org", "code" : "35200-5", "display" : "Cholesterol [Moles/volume] in Serum or Plasma" }], "text" : "Cholesterol" } }, { "code" : { "coding" : [{ "system" : "http://loinc.org", "code" : "35217-9", "display" : "Triglyceride [Moles/volume] in Serum or Plasma" }], "text" : "Triglyceride" } }, { "code" : { "coding" : [{ "system" : "http://loinc.org", "code" : "2085-9", "display" : "HDL Cholesterol" }], "text" : "Cholesterol in HDL" } }, { "code" : { "coding" : [{ "system" : "http://loinc.org", "code" : "13457-7", "display" : "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation" }], "text" : "LDL Chol. (Calc)" } }], "medication" : [{ "code" : { "coding" : [{ "system" : "http://www.nlm.nih.gov/research/umls/rxnorm", "code" : "203151", "display" : "Gemfibrozil" }] } }], "plan" : [{ "reference" : { "reference" : "http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6" } }] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-snapshot3 generated on Wed, Dec 14, 2022 07:16+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change